SoMex Research & Health Organisation
banner11 banner22 banner33 banner44

News & Events

Head & Neck Squamous Cell Carcinoma.

CBKM120H2201- Phase II multicenter randomized, double blind, placebo controlled study assessing the efficacy of buparlisib (BKM120) plus paclitaxel vs. placebo plus paclitaxel in patients with platinum pre-treated recurrent or metastatic head and neck squamous cell carcinoma.

Other News